EC Number   |
Disease |
PubMed ID |
Title of Publication  |
Category |
Confidence Level |
|---|
    6.2.1.2 | Macular Degeneration |
17983602 |
A Stargardt disease-3 mutation in the mouse Elovl4 gene causes retinal deficiency of C32-C36 acyl phosphatidylcholines. |
causal interaction
unassigned |
2
0 |
| 6.2.1.2 | Adrenoleukodystrophy |
21039332 |
ABC Subfamily D Proteins and Very Long Chain Fatty Acid Metabolism as Novel Targets in Adrenoleukodystrophy. |
causal interaction
therapeutic application
unassigned |
4
4
0 |
| 6.2.1.2 | Liver Cirrhosis |
30380656 |
Advanced Liver Fibrosis Is Independently Associated with Palmitic Acid and Insulin Levels in Patients with Non-Alcoholic Fatty Liver Disease. |
diagnostic usage
unassigned |
4
0 |
| 6.2.1.2 | Obesity |
28869586 |
Alterations in fatty acid metabolism in response to obesity surgery combined with dietary counseling. |
unassigned |
0 |
| 6.2.1.2 | Adenocarcinoma |
34364947 |
An evaluation of carcinogenicity predictors from short-term and sub chronic repeat-dose studies of agrochemicals in rats: Opportunities to refine and reduce animal use. |
diagnostic usage
therapeutic application
unassigned |
1
3
0 |
| 6.2.1.2 | Neoplasms |
34364947 |
An evaluation of carcinogenicity predictors from short-term and sub chronic repeat-dose studies of agrochemicals in rats: Opportunities to refine and reduce animal use. |
diagnostic usage
therapeutic application
unassigned |
1
3
0 |
| 6.2.1.2 | Insulin Resistance |
29043930 |
Associations Among Fatty Acids, Desaturase and Elongase, and Insulin Resistance in Children. |
unassigned |
0 |
| 6.2.1.2 | Metabolic Diseases |
29043930 |
Associations Among Fatty Acids, Desaturase and Elongase, and Insulin Resistance in Children. |
unassigned |
0 |
| 6.2.1.2 | Insulin Resistance |
17906635 |
Crucial role of a long-chain fatty acid elongase, Elovl6, in obesity-induced insulin resistance. |
ongoing research
therapeutic application
unassigned |
1
4
0 |
| 6.2.1.2 | Obesity |
17906635 |
Crucial role of a long-chain fatty acid elongase, Elovl6, in obesity-induced insulin resistance. |
ongoing research
therapeutic application
unassigned |
1
4
0 |
